ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Na Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.